We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 702

New Suit Challenges CMS On When Overpayments Are “Identified”
  • Sidley Austin LLP
  • USA
  • February 8 2016

A new lawsuit filed against CMS challenges the agency's position on when a healthcare entity will be deemed to have "identified" an overpayment - an


Proposed Amendments to Singapore’s Pharmaceutical Laws
  • Sidley Austin LLP
  • Singapore
  • February 3 2016

Singapore's Health Sciences Authority (HSA) held its second consultation on proposed subsidiary legislation to consolidate regulatory controls for


Amicus Briefs Ask Supreme Court to Rein In The Implied Certification Theory (Part Two)
  • Sidley Austin LLP
  • USA
  • February 3 2016

As we previously reported, the Supreme Court's pending decision in United Health Services, Inc. v. United States ex rel. Escobar has attracted a


Amicus Briefs Ask Supreme Court to Rein In The Implied Certification Theory (Part One)
  • Sidley Austin LLP
  • USA
  • January 28 2016

As we have previously reported, the Supreme Court will decide a case this term that will address the viability and scope of the implied certification


Sidley Global Pricing newsletter - V4 2016
  • Sidley Austin LLP
  • Spain, Sweden, United Kingdom, USA, China, European Union, France, Germany, India, Netherlands, Australia, Belgium, Canada
  • January 27 2016

The Australian Pharmaceutical Benefits Pricing Authority (PBPA) ceased operations on April 1, 2014, in a move by the government to improve drug


New Guidance Reflects Heightened FDA Focus on Medical Device Cybersecurity
  • Sidley Austin LLP
  • USA
  • January 26 2016

On January 15, 2016, the Food and Drug Administration (FDA) issued new guidance that, for the first time, recommends routine postmarketing


The Wait Is Over: CMS Issues Final Rule With Comment Period Addressing Medicaid Drug Reimbursement and Rebates
  • Sidley Austin LLP
  • USA
  • January 23 2016

On January 21, 2016, the Centers for Medicare and Medicaid Services (CMS or the Agency) released an advance-print copy of the long-awaited final rule


Relators Argue Fourth Circuit Must Permit Use of Sampling to Establish FCA Liability
  • Sidley Austin LLP
  • USA
  • January 20 2016

The Fourth Circuit has agreed to consider on interlocutory appeal whether statistical sampling can be used to establish FCA liability, as we


FDA continues scrutiny of direct-to-consumer genetic testing
  • Sidley Austin LLP
  • USA
  • January 13 2016

The Food and Drug Administration (FDA) recently released three untitled letters from the Office of In Vitro Diagnostics and Radiological Health (OIR


OCR Issues Clarifying Guidance on HIPAA’s Individual Access Right
  • Sidley Austin LLP
  • USA
  • January 12 2016

On January 7, the U.S. Department of Health and Human Services Office for Civil Rights (OCR) issuedguidance on the Health Insurance Portability and